在患有自身免疫性血小板狭窄症的患者中进行克隆性血液形成:国际多中心研究
Bruno Fattizzo1,2, Alfredo Marchetti1,2, Alessandro Bosi1,2
1Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Blood advances
|November 13, 2024
概括
通过下一代测序 (NGS) 识别的克隆性血液形成,在18%的成年免疫血栓塞 (ITP) 患者中流行. 这一发现与年龄较大,耐火性疾病以及较高的血栓并发症风险有关.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 区分免疫性血小板缺血 (ITP) 和其他疾病,如骨髓质疏松综合征可能是具有挑战性的.
- 下一代测序 (NGS) 提供了一种检测体质突变的方法,有助于诊断.
- 克隆性造血 (CH) 是血液造血干细胞中体性突变的存在.
研究的目的:
- 为了确定成年ITP患者中CH的患病率.
- 调查CH在ITP中的临床意义和关联.
- 探索CH与治疗反应或不良事件之间的关系.
主要方法:
- 一个多中心的回顾性观察性研究,涉及167名成年ITP患者.
- 从ITP开始后平均3.6年后进行的NGS评估.
- 分析突变数据,不包括生殖系变异和多态,以定义CH.
主要成果:
- 18.5% (31/167) 的患者表现出CH,在TET2,DNMT3A,SRSF2和ASXL1.1中存在常见突变.
- CH在老年男性中更为频繁,并且与二线治疗的时间更短有关,特别是与血栓形成素受体激动剂 (TPO-RAs) 的治疗.
- CH显著增加了血栓形成风险 (26% vs 8%,P=.01),独立于TPO-RA使用,但受年龄的影响.
结论:
- 在成年ITP患者中,CH在很大一部分人群中普遍存在.
- 冠状动脉病与特定的临床特征有关,包括老年和耐火性疾病.
- CH是ITP中血栓性并发症的独立风险因素.
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
01:21Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
01:22Bone Marrow Sampling and Transplants
286
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
286